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Abstract
Background—The psychosocial benefits of postmastectomy breast reconstruction are well 
established; however, health care barriers persist. The authors evaluated statewide patient 
population to further identify obstacles to reconstruction.
Methods—A linked data set combining the North Carolina Central Cancer Registry with 
administrative claims from Medicare, Medicaid, and private insurance plans identified women 
diagnosed with breast cancer from 2003 to 2006. For inclusion in the study, women must have had 
a mastectomy within 6 months of diagnosis and had continuous insurance enrollment at least 2 
years postoperatively (n = 5381). Multivariable logistic regression was used to model odds of 
reconstruction.
Results—Approximately 20 percent underwent reconstruction (n = 1130). Distance to a plastic 
surgeon—10 to 20 miles (OR, 0.78) and greater than 20 miles (OR, 0.73; p < 0.05)—was 
significantly predictive of no reconstruction, independent of other well-known disparities, 
including age, race, rural location, and lower household income. Women with government-funded 
health care, such as Medicare (OR, 0.58) and Medicaid (OR, 0.24; p < 0.001), were also 
significantly less likely to undergo reconstruction. Consistent with previous study, advanced 
cancer stage and receipt of radiation therapy decreased the likelihood of reconstruction. 
Furthermore, when the authors compared immediate to delayed reconstruction, rural location, 
chemotherapy, and radiation therapy were significantly predictive of delay.
Conclusions—This is the first population-based study to demonstrate distance to care and 
insurance plan as significant predictors of receipt of reconstruction. Additional research is needed 
to understand health care barriers and to determine whether distance to a plastic surgeon can be 
ameliorated by outreach programs.
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The psychosocial benefits of postmastectomy breast reconstruction, including improvements 
in self-esteem, sexuality, and body image, are well documented.1–3 They hold true for 
reconstruction performed at the time of mastectomy (immediate) and that performed in a 
separate setting (delayed).4 Despite undisputed benefits, access to breast reconstruction, 
regardless of timing, remains limited by socioeconomic and demographic factors. Previously 
published data confirm age, race, level of education, income level, and geographic location 
as barriers to reconstruction.5,6 Density of plastic surgeons per state of residence6 and type 
of health insurance7 have also been recently identified as additional barriers to breast 
reconstruction. We evaluated our state-based patient population to further investigate these 
and further obstacles to reconstruction. Specifically, we queried whether geographic distance 
to a plastic surgeon would affect a woman’s likelihood of having the procedure. We 
compared barriers to reconstruction across public and private health insurance. Finally, we 
assessed whether timing of reconstruction, either immediate or delayed, affected these 
variables. We hypothesized that greater distance from a plastic surgeon would lower the 
likelihood of receipt of reconstruction and that this effect might be mitigated with the 
inclusion of the delayed cohort.
PATIENTS AND METHODS
Data
The Integrated Cancer Information and Surveillance System is a state-based data set that 
represents the linkage of the North Carolina Central Cancer Registry to beneficiaries in 
Medicare, Medicaid, and private insurance plans across the state. The linked Integrated 
Cancer Information and Surveillance System data represent approximately 80 percent of the 
North Carolina population with cancer through 2010. Cancer registry data were available for 
all incident breast cancer cases diagnosed from 2003 to 2006; the insurance administrative 
data include monthly enrollment data and inpatient, outpatient, and professional claims.
Study Sample
We included all breast cancer cases other than those with inflammatory disease or diagnosed 
at death or autopsy between 2003 and 2006 (n = 27,638) (Fig. 1). Patients were excluded if 
they had distant metastatic disease (n = 1058), multiple breast cancers (n = 747) or more 
than one primary cancer within 3 years before or 1 year after diagnosis (n = 550). Women 
were also excluded if they did not undergo a mastectomy (n = 17,766) or mastectomy was 
performed more than 6 months after diagnosis (n = 733). To be certain that we captured all 
potential health care use related to reconstruction, we required continuous insurance 
enrollment for 2 years following the date of undergoing mastectomy (excluding n = 1377). 
Lastly, we excluded 26 patients who were simultaneously enrolled in Medicare, Medicaid, 
and private insurance. The final cohort included 5381 patients who met all study inclusion 
and exclusion criteria.
Exposure and Outcome Measurement
We stratified the sample by insurance payer to calculate distances to the nearest possible 
surgeon who performs breast reconstruction. Geographic coordinates for the surgeon were 
identified based on the zip code centroid reported on all possible claims for breast 
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reconstruction within each payer. This provided the coordinates to all possible surgeons 
performing reconstruction within that payer. Straight-line distances were then calculated 
between the nearest possible surgeon (within their payer) and the patient’s address at 
diagnosis. Actual distance to reconstruction was also calculated for those women who 
underwent reconstruction and was based on the zip code reported on the first claim for 
reconstruction. Based on thresholds observed in previous literature,8,9 we then categorized 
distance to provider into three groups, less than 10 miles, 10 to 20 miles, and greater than or 
equal to 20 miles.
To examine outcomes, we dichotomized the cohort into women who received breast 
reconstruction within 2 years from the date of mastectomy compared with women with no 
evidence of breast reconstruction. We further stratified the women who received 
reconstruction by the timing of their reconstruction. In keeping with previously published 
Surveillance, Epidemiology, and End Results data, women were classified as receiving 
“immediate” reconstruction if it was performed less than 4 months after mastectomy; any 
reconstruction initiated 4 or more months after mastectomy was considered “delayed” 
reconstruction.
Covariates
Patient demographic and tumor characteristics were defined using data from the cancer 
registry. These included the following covariates measured at the time of the patient’s 
diagnosis: patient age, race, year of diagnosis, cancer stage, and estrogen receptor and 
progesterone receptor status. Patient comorbidities measured by the Charlson index were 
defined using the insurance claims data. Claims data also provided relevant breast cancer 
treatment information, including receipt of chemotherapy, radiation therapy, and the type of 
breast reconstruction. Socioeconomic covariates included an indicator of rurality using rural-
urban commuting area codes and census tract level of median household income for 2005 to 
2009 from the American Community Survey.
Analytic Strategy
Crude analyses were performed to examine the associations between each covariate and 
breast reconstruction. In the entire cohort (n = 5381), logistic regression was used to 
estimate the odds of receiving postmastectomy breast reconstruction (versus not). We were 
specifically interested in the effect of distance defined as the straight-line distance from the 
patient’s home to the closest surgeon reimbursed for reconstruction by that patient’s 
insurance. In the subset of women who underwent reconstruction (n = 1130), logistic models 
were also used to estimate the odds of receiving delayed reconstruction (versus immediate) 
while controlling for covariates. Among these women who underwent reconstruction, 
distance was measured as the actual distance to the surgeon who was reported on that 
patient’s claim. All logistical models were adjusted for covariates, including age, race, year 
of diagnosis, stage, estrogen/progesterone receptor status, comorbidity index, receipt of 
chemotherapy and radiation therapy, type of insurance, rural/urban,10 census tract measure 
of income, and type of reconstruction. Sensitivity analyses were conducted excluding 
individuals with missing distance information. SAS 9.4 (SAS Institute, Inc., Cary, N.C.) 
analytic software was used.
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RESULTS
Approximately 20 percent of patients underwent postmastectomy breast reconstruction (n = 
1130) (Table 1).
Distance to a breast reconstructive surgeon was significantly associated with receipt of 
reconstruction. This effect was independent of other well-known predictors of health 
disparities, including age, race, rurality, and lower household income. Women living 10 to 
20 miles from the nearest surgeon had approximately 22 percent lower odds of undergoing 
breast reconstruction (OR, 0.78; 95 percent CI, 0.63 to 0.96), and women living 20 miles or 
more from the nearest surgeon had 27 percent lower odds (OR, 0.73; 95 percent CI, 0.57 to 
0.93) compared with women who lived within 10 miles (Fig. 2).
Women with federally funded health care [i.e., Medicaid (OR, 0.24; 95 percent CI, 0.19 to 
0.32) and Medicare (OR, 0.58; 95 percent CI, 0.45 to 0.74)] had significantly lower odds of 
undergoing reconstruction compared with women with private insurance. Minority women 
had 50 percent lower odds of receiving reconstruction compared to non-Hispanic whites 
(OR, 0.48; 95 percent CI, 0.37 to 0.61) (Table 2). Consistent with previous studies,5,6 
increasing age at diagnosis, advanced cancer stage, and receipt of radiation therapy also 
decreased the odds of reconstruction. Effect sizes were of similar magnitude and precision in 
the sensitivity analyses, excluding observations with missing distance information.
Among women who received reconstruction (n = 1130), distance to the actual performing 
surgeon was not associated with whether or not a woman received immediate versus delayed 
reconstruction (Table 3). However, delayed reconstruction was associated with rural county 
of residence, chemotherapy, and radiation therapy. Women living in rural counties were 63 
percent more likely to receive delayed reconstruction after controlling for other covariates 
(OR, 1.63; 95 percent CI, 1.11 to 2.38) (Table 4).
DISCUSSION
Breast reconstruction has repeatedly been shown to be of psychosocial benefit for breast 
cancer patients.1,3 Nevertheless, only 21 percent of our patients underwent postmastectomy 
reconstruction, and this is consistent with other reports in the literature.11 Because breast 
reconstruction has well-documented psychosocial benefits, it remains concerning that such a 
small proportion of women receive treatment.1–3 We believe immediate breast 
reconstruction, when possible, is the preferred approach; however, only 16 percent of our 
patients underwent immediate postmastectomy reconstruction. When queried, nearly half of 
women who underwent delayed breast reconstruction would have preferred to have it 
performed in an immediate setting.12 The aesthetic results of immediate versus delayed 
reconstruction are arguably superior11,13 and, more importantly, patients report lower 
psychological health disturbance scores when they undergo reconstruction at the time of 
mastectomy.14 Although the American College of Surgeons National Accreditation Program 
for Breast Centers guidelines require that patients are offered a preoperative referral to a 
reconstructive/plastic surgeon,15 this is far from universal. In fact, the study in 2008 by 
Alderman et al. revealed that only 33 percent of patients report their general surgeon even 
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discussed breast reconstruction with them. This was irrespective of tumor behavior (ductal 
carcinoma in situ versus invasive) and comorbidities. The likelihood of this discussion, 
however, was increased in younger patients with higher levels of education.16 Faced with 
relatively low use rates of breast reconstruction, we are left to question what barriers remain 
between patients facing mastectomy and surgeons who can reconstruct their breast(s).
This is the first population-based study to demonstrate distance to care and insurance carrier 
as significant predictors of receipt of breast reconstruction. Our data also suggest that this 
particular barrier to care (distance) may be ameliorated when breast reconstruction occurs in 
a delayed fashion. Clinically, this is not an unexpected finding. The local oncologic team 
(i.e., breast surgeon, medical oncologist, radiation oncologist, and radiographer) may not 
routinely include a plastic surgeon or one who accepts the patient’s health insurance. It is 
also possible that the referring surgeons are consciously or unconsciously aware of patients’ 
geographic and insurance barriers and that this too affects their decision-making. Age, 
previously identified as a bias affecting discussion of breast reconstruction, is also a proxy 
variable for those more likely to have private insurance, as women who were younger, white, 
and residing in urban areas were more likely to have private insurance.
In the delayed setting, the immediate needs of the cancer patient (i.e., excision and adjuvant 
therapies) have been addressed and the patient is free to pursue other goals, which may 
include breast reconstruction. Some limitations, such as travel distance to a reconstructive 
surgeon, may be addressed by the elective timing of delayed reconstruction (e.g., financial 
savings or leave from work).
Strengths of our study include access to a unique cancer registry–linked claims database, 
which includes women from multiple payers. Our study includes claims from federally 
funded insurance and from private payers. We were also uniquely able to capture both 
immediate and delayed breast reconstruction claims (i.e., claims >4 months from 
mastectomy). Furthermore, we have the ability to assess World Health Organization files 
claims for breast reconstruction by analyzing provider specialty codes. Using specialty 
information provided in the claims, approximately 95 percent of procedures were performed 
by plastic surgeons. These patterns of specialty care concurred with the American Society of 
Plastic Surgeons roster describing active surgeons across the state and, when compared, 
suggests that nearly all providers of plastic surgery are board certified and self-report as 
plastic surgeons for billing purposes.
Limitations of our study include unmeasured confounders such as individual income levels, 
patient choice, and decision-making, which may be more significant in breast reconstruction 
than in reconstruction of defects caused by other cancers. Distance was measured by a 
Euclidean (straight-line) method. However, road networks or traffic conditions may also be a 
consideration when seeking surgery. We also located providers within zip code centroids, 
which are less sensitive than actual practice address. This study focused on the state of North 
Carolina, and findings may not be generalizable to other populations. However, North 
Carolina is the ninth largest state and is racially and geographically diverse (35 percent 
racial/ethnic minority; 40 percent rural).17
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Relocation of patients or surgeons is not a practical solution to address distance as a barrier 
to reconstruction. Perhaps, however, a significant impact on breast reconstruction use may 
be made through novel outreach options. We, and others, have initiated options such as early 
staged reconstruction techniques and telemedicine. For example, we allow patients to 
continue all other cancer care in the community (e.g., chemotherapy, physical therapy, 
radiation therapy) and travel only for breast reconstruction. If the reconstruction is 
performed early (e.g., within 14 days of locally performed mastectomy), it can achieve 
similar or even improved aesthetic results compared with immediate breast reconstruction.18 
Furthermore, we offer plastic surgery teleconsultation for patients who are unable to travel to 
our center. Although eventually they will have to arrange transportation for surgery and 
follow-up, they are educated as to their options without the financial and logistical 
difficulties of travel upfront. We remain optimistic about the potential for outreach. We need 
more data and additional research into these novel approaches to compare outcomes of 
staged reconstruction and telemedicine.
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Fig. 1. 
Cohort creation.
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Fig. 2. 
Proportion of breast cancer patients undergoing reconstruction after mastectomy and 
geographic density of providers by insurance type from 2003 to 2006 in North Carolina.
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Table 1
Cohort Creation
Selection Criteria
No. of Included 
Patients (%)
No. of Excluded 
Patients (%)
Female breast cancer (exclusion of inflammatory breast cancer) diagnosed between 2003 
and 2006, not diagnosed by death certificate or autopsy
27,638
Excluded distant metastatic patients for 2-yr cohort 26,580 (96) 1058 (4)
Include only one breast cancer diagnosis patients 25,833 (97) 747 (3)
Exclude other origin cancer diagnosed within 3 yr before and 1 yr after breast cancer 
diagnosis
25,283 (98) 550 (2)
Received mastectomy 7517 (30) 17,766 (70)
Received mastectomy within 6 mo after diagnosis 6784 (90) 733 (10)
Continuous coverage through 2 yr after mastectomy 5407 (80) 1377 (20)
Excluded patients enrolled in Medicare, Medicaid, and private 5381 (100) 26 (0)
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Table 3
Model for Receipt of Any Postmastectomy Breast Reconstruction
Variables OR (95% CI)
Age at diagnosis 0.90 (0.89–0.91)§
Cancer stage
 0/I Referent
 II/III 0.75 (0.61–0.93)†
 Unknown 1.11 (0.42–2.91)
Charlson score
 0 Referent
 1+ 0.88 (0.67–1.17)
 Unable to assess 1.75 (1.41–2.17)§
Chemotherapy
 No Referent
 Yes 1.10 (0.89–1.37)
Distance between home address and the nearest surgeon performing breast reconstruction within each payer cohort
 <10 miles Referent
 10–20 miles 0.78 (0.63–0.96)†
 ≥20 miles 0.73 (0.57–0.93)†
 Missing 0.57 (0.08–3.93)
ER and PR status
 ER- or PR-positive Referent
 ER- and PR-negative 0.99 (0.76–1.30)
 Borderline/undetermined/unknown 0.82 (0.64–1.05)
First or only cancer diagnosis
 No 0.89 (0.71–1.13)
 Yes Referent
Insurance type
 Private only Referent
 Medicare or Medicare with Private 0.58 (0.45–0.74)§
 Any Medicaid 0.24 (0.19–0.32)§
Median household income quartile 2005–2009 (census tract)
 First 0.68 (0.52–0.89)‡
 Second 0.73 (0.57–0.94)†
 Third 0.86 (0.68–1.07)
 Fourth Referent
 Not available 0.56 (0.37–0.84)‡
Race
 Non-Hispanic white Referent
 Others 0.48 (0.37–0.61)§
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Variables OR (95% CI)
Radiation therapy
 No Referent
 Yes 0.43 (0.34–0.54)§
Rural (county)
 No Referent
 Yes 0.65 (0.54–0.79)§
Year of diagnosis
 2003 Referent
 2004 1.47 (1.12–1.92)‡
 2005 1.25 (0.91–1.73)
 2006 1.42 (1.03–1.96)†
*
Logistic regression result (reconstruction = 1 vs. not = 0) OR < 1: less likely to undergo reconstruction (use continuous age variable). Total no. of 
observations, 5381; total no. of observations used, 5381; model fit Akaike information criterion = 3803.092.
†p < 0.05.
‡p < 0.01.
§p < 0.001.
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Table 4
Model for Receipt of Delayed Reconstruction*
Variables OR (95% CI)
Age at diagnosis 0.98 (0.96–1.00)†
Cancer stage
 0/I Referent
 II/III 1.36 (0.90–2.05)
 Unknown 1.56 (0.16–15.17)
Charlson score
 0 Referent
 1+ 1.13 (0.63–2.05)
 Unable to assess 1.11 (0.76–1.62)
Chemotherapy
 No Referent
 Yes 2.42 (1.62–3.63)‡
Distance between home address and the actual performing surgeon
 <10 miles Referent
 10–20 miles 0.81 (0.54–1.22)
 ≥20 miles 0.88 (0.59–1.31)
 Missing 1.44 (0.51–4.06)
ER and PR status
 ER- or PR-positive Referent
 ER- and PR-negative 1.45 (0.92–2.29)
 Borderline/undetermined/unknown 1.22 (0.76–1.98)
First or only cancer diagnosis
 No 0.82 (0.50–1.36)
 Yes Referent
Insurance type
 Private only Referent
 Medicare or Medicare with private 0.93 (0.56–1.54)
 Any Medicaid 1.24 (0.76–2.04)
Median household income quartile 2005–2009 (census tract)
 First 1.14 (0.69–1.89)
 Second 1.42 (0.91–2.20)
 Third 1.33 (0.89–1.98)
 Fourth Referent
 Not available 0.95 (0.42–2.11)
Race
 Non-Hispanic white Referent
 Others 0.76 (0.48–1.21)
Radiation therapy
 No Referent
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Variables OR (95% CI)
 Yes 1.55 (1.03–2.34)†
Rural (county)
 No Referent
 Yes 1.63 (1.11–2.38)†
Type of reconstruction
 Implant-based Referent
 Autologous with tissue expander or implant 1.37 (0.85–2.22)
 Autologous alone 2.24 (1.55–3.22)‡
 Not otherwise specified 1.78 (0.44–7.26)
Year of diagnosis
 2003 Referent
 2004 1.52 (0.92–2.50)
 2005 1.40 (0.75–2.61)
 2006 1.24 (0.66–2.33)
*
Logistic regression result (immediate = 0 vs. delay = 1) OR < 1: less likely to undergo delayed reconstruction (use continuous age variable); 1130 
read, 1130 used. Model fit Akaike information criterion = 1131.078.
†p < 0.05.
‡p < 0.001.
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